Table 4.
Control, case | Control, case | 100 000 permutation, | |||
---|---|---|---|---|---|
SNPs | ratio counts | frequencies | Chi-square | P-valuea | P-value |
(a) Male IgA nephropathy patients | |||||
rs6957 | 537:91, 228:60 | 0.855, 0.792 | 5.77 | 0.016 | 0.08 |
rs2241715 | 462:168, 191:99 | 0.733, 0.659 | 5.381 | 0.020 | 0.09 |
rs1800471 | 581:47, 259:27 | 0.925, 0.906 | 1.011 | 0.314 | NS |
rs1982073 | 411:217, 158:130 | 0.654, 0.549 | 9.401 | 0.002 | 0.02 |
rs1800469 | 460:168, 186:102 | 0.732, 0.646 | 7.132 | 0.007 | 0.04 |
(b) Female IgA nephropathy patients | |||||
rs6957 | 52:252, 22:108 | 0.171, 0.169 | 0.002 | 0.9631 | NS |
rs2241715 | 92:214, 34:98 | 0.301, 0.258 | 0.835 | 0.3608 | NS |
rs1800471 | 285:23, 120:12 | 0.925, 0.909 | 0.333 | 0.5641 | NS |
rs1982073 | 116:190, 49:83 | 0.379, 0.371 | 0.024 | 0.876 | NS |
rs1800469 | 93:215, 36:94 | 0.302, 0.277 | 0.276 | 0.5996 | NS |
aUncorrected.